Table 1.
Details of patient demographics, tumor features, and treatments as per included case reports and series. Data are reported as number (%) or mean (range). Abbreviations: IDC: infiltrating ductal carcinoma, TNBC: triple-negative breast carcinoma, mo: months.
| Variable | No. reported (out of 92 patients) | Count (%) or Mean (range) |
|---|---|---|
| Age (y) | 48 (52.17 %) | 54.8 (28–91) |
| 90 (97.82 %) | ||
| Female | 84 (93.33 %) | |
| Male | 6 (6.66 %) | |
|
Baseline Functional Status |
16 (17.39 %) |
ECOG 0: 3 |
| ECOG 0–1: 1 | ||
| ECOG 1: 2 | ||
| ECOG 2: 1 | ||
| WHO 1: 1 | ||
| WHO 2: 4 | ||
| WHO 3: 2 | ||
| PS4: 1 | ||
| KPS 60 %: 1 | ||
| Tumor presentation | 71 (77.17 %) | |
| Primary | 54 (76.05 %) | |
| Recurrent | 17 (23.94 %) | |
| Tumor duration (mo) | 50 (54.34 %) | 12.14 (1–72) |
| Tumor size | 57 (61.96 %) | |
|
Tumor histology |
54 (58.7 %) |
IDC (19) |
| Phyllodes tumor (15) | ||
| Mucinous carcinoma (5) | ||
| Adenocarcinoma (4) | ||
| Others: | ||
| Plasmacytoma (1) | ||
| Malignant fibrous histiocytoma (1) | ||
| Osteosarcoma (1) | ||
| Angiosarcoma (1) | ||
| Infiltrating carcinoma (1) | ||
| Epithelial metaplastic carcinoma (1) | ||
| Stromal sarcoma (1) | ||
| Medullary carcinoma (1) | ||
| Mixoid colloid carcinoma (1) | ||
| Pleomorphic sarcoma (1) | ||
| Sarcoma + IDC (1) | ||
| Presence of metastases | 66 (71.74 %) | Yes: 28 |
| No: 38 | ||